In Shizuoka, two people who ingested the recalled products were temporarily hospitalized in Shizuoka, following an issue in which people who ingested health foods containing Kobayashi Pharmaceutical's red yeast rice developed kidney disease. A hospital in the prefecture held a press conference and revealed symptoms such as nausea and the situation in which renal dysfunction was confirmed.
On the evening of the 28th, a press conference was held at Fuji City Central Hospital in Fuji City, Shizuoka Prefecture.
According to the press conference, two people who had taken Red Yeast Choleste Help were temporarily hospitalized at this hospital, and one of them developed symptoms such as nausea after taking it for several months. He complained of this, and at the medical institution he visited, renal dysfunction was confirmed and he was hospitalized.
She recovered within a few weeks and was discharged from the hospital, but after restarting the product, she became ill again and was readmitted to the hospital.
The other person continued to take the drug for about 6 months, complained of similar symptoms such as nausea, and was admitted to the hospital after kidney dysfunction was confirmed.
The two people have already been discharged from the hospital, and the hospital contacted Kobayashi Pharmaceutical last week as it suspected a causal relationship with the ingestion of the product.
In addition, Yasuhito Takahashi, director of the nephrology department at Fuji City Central Hospital, said that there have been multiple inquiries from people who have ingested health foods that contain the ingredients of red yeast rice. It is important for people who suspect this to consult a medical institution or public health center as soon as possible."